lets all stop looking at short term moves and look at the big picture...they developed 1 approved drug and a 2nd on the way that should prove to be "best in class"...obviously time will tell...but will have a much better idea with ponatinib in the EPIC trial and over the next several months to year with ap26113 as more data is released.
Nobody likes to see their stock portfolio go south but only temparary.My belief is that low to mid 18's is good support.
Smart money is buying..scared money is selling!!!!
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.